The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled

EuroIntervention 2015;10:1396-1401 published online ahead of print April 2014. DOI: 10.4244/EIJV10I12A243

1. Instituto de Cardiologia Dante Pazzanese, Sao Paulo, Brazil; 2. Centro Cardiologico Monzino, IRCCS, University of Milan, Milan, Italy; 3. St Vincent’s Hospital, Fitzroy, Victoria, Australia; 4. Thoraxcenter, Erasmus University Medical Center, Rotterdam

Aims: The safety and performance of the Absorb Bioresorbable Vascular Scaffold (Absorb BVS) system (Abbott Vascular, Santa Clara, CA, USA) has been previously established in 131 patients

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Five-year outcomes of staged percutaneous coronary intervention in the SYNTAX study

Latest news